New York, May 17 (SocialNews.XYZ) The US Food and Drug Administration has declined to approve antidepressant fluvoxamine as a treatment for Covid-19 as data is insufficient to conclude its effectiveness against the virus. Fluvoxamine has.
VIEW MORE : https://bit.ly/1breakingnews